Arunis Abode Ltd
ARUNISArunis Abode Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: the price moved +1,001.2% in a year while annual EPS moved −133.3% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a confirmed uptrend (66 weeks in) while the P/E sits at the 55th percentile of its own 4-year range. Underneath, the last four quarters read mixed. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Arunis Abode Ltd trades at ₹88.3, in a confirmed uptrend and 66 weeks into that stage. That is +65.5% against its own 200-day average. It sits at 89% of a 52-week range of ₹7 to ₹98. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 39 straight weeks.
Today the stock is in a confirmed uptrend — week 66 of stage 2, confirmed. At ₹88.3 it trades +65.5% versus its 200-day average and sits at 89% of its 52-week range (₹7–₹98).
Against the market, two honest reads. Cumulative: over the last 10.0 years the stock moved +58,780% while the NIFTY 500 moved +250% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 39 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Arunis Abode Ltd trades at 62.5× P/E, mid-range by its own standards (55th percentile). Its long-run median P/E is 59.4×, measured across 3.8 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 62.5× is mid-range by its own standards (55th percentile), against a long-run median of 59.4× measured over 3.8 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved −133.3% against a +1,001.2% price move — the price outran earnings, pushing the multiple UP its own range.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read.
Arunis Abode Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 6 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
4-Factor Sector Score
50.9/100 — rank 16 of 20 in Diversified · 45% evidence confidence · provisional, ranked below fully-evidenced peers
Arunis Abode Ltd scores 50.9 out of 100 against the 20 companies it is compared with in Diversified, ranking 16. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 15.3 + 9.5 + 9.4 + 16.7 = 50.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Arunis Abode Ltd reported ₹15.1 Cr of revenue in the Dec 25 quarter. The last full year, FY25, came in at ₹0.0 Cr. The last four reported quarters add to ₹46.7 Cr. A multi-year compound rate is not shown because the annual history behind it is too short to compute one honestly.
FY25 revenue came in at ₹0.0 Cr (−100.0% on the year). The latest quarter (Dec 25) printed ₹15.1 Cr, null year on year.
Acceleration check: trailing-twelve-month revenue grew +17,181.5% over the last 4 quarters against +293.7%/yr over the last 8 — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Arunis Abode Ltd's operating margin is 28.5% in the Dec 25 quarter. Across 3 fiscal years the operating margin has ranged 1.0% to 74.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 28.5%, null pp against the same quarter a year ago. Across 3 fiscal years the operating margin has ranged 1.0%–74.0%.
🚨 Why the margin moved: operating margin went −35.1 pp year on year while gross margin went −59.0 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Arunis Abode Ltd earned ₹2.5 Cr of net profit in the Dec 25 quarter. Full-year FY25 profit was ₹0.0 Cr. That is 16.3% of the quarter's revenue. The same quarter a year earlier lost ₹0.2 Cr. 4 of the last 12 reported quarters were loss-making.
Dec 25 profit was ₹2.5 Cr, null year on year. On the full year, FY25 printed ₹0.0 Cr (null).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Arunis Abode Ltd's cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was ₹−1.0 Cr of operating cash against ₹0.0 Cr of profit. After ₹−2.0 Cr of capital spending, ₹1.0 Cr was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
FY25: operating cash of ₹−1.0 Cr against reported profit of ₹0.0 Cr, leaving free cash of ₹1.0 Cr after ₹−2.0 Cr of capital spending.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Arunis Abode Ltd's cash conversion cycle runs 0 days in FY24, down from 0 days in FY22. Capital spending ran ₹−1.0 Cr over the last 3 years.
FY24: debtors at 0 days (an asset-light business — no inventory to speak of) — for a full cycle of 0 days, tighter than FY22's 0.
On the investment side: capital spending of ₹−1.0 Cr over the last 3 fiscal years. Capital work-in-progress stands at ₹0.0 Cr (FY25) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Arunis Abode Ltd earns a ROCE of −5% in FY25. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 0.0% net margin on 0.13× asset turns.
FY25 ROCE is −5%.
Why the return is what it is — the wiring (FY24): 0.0% net margin × 0.13× asset turns × 1.33× balance-sheet leverage ≈ 0.0% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Arunis Abode Ltd carries ₹1.0 Cr of borrowings against ₹6.0 Cr of equity in FY25, a debt-to-equity of 0.17. Over 3 years borrowings went from ₹2.0 Cr to ₹1.0 Cr. Capital spending ran ₹−1.0 Cr across the last 3 of those years.
FY25: borrowings of ₹1.0 Cr against equity of ₹6.0 Cr — a debt-to-equity of 0.17. Over 3 years borrowings went from ₹2.0 Cr to ₹1.0 Cr while capital spending ran ₹−1.0 Cr in just the last 3 — the build-out is being paid for out of cash, not debt.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 56.3 points of Arunis Abode Ltd over 8 quarters, the biggest move on the register. That takes promoters to 13.9% of the company. Domestic institutions moved +0.7 points over the same window, to 0.7%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −56.3 points over 8 quarters to 13.9%; Domestic institutions: +0.7 points over 8 quarters to 0.7%. Note the structure: promoters hold under 20% — this is a widely-held company where institutions, not a family, set the direction.
🚨 Why the register moved: promoters drove it (−56.3 points), absorbed on the other side by domestic institutions (+0.7 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Arunis Abode Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Sobhagya Mercantile Ltd512014 | 65.9/100Favorable setup75% evidence | TURNING | 19.5/35 Revenue 49.3% · PAT 41.8% · OPM change -0.5 pp 95% evidence | 19.1/25 ROCE 23.4% · OPM 14.4% 76% evidence | 9.7/20 P/E 61.1× · PEG — 15% evidence | 17.6/20 RS sector 31% · RS bench 32.9% · 1Y 61.9%6 of 12 weeks ahead 100% evidence |
| Exact sum: 19.5 + 19.1 + 9.7 + 17.6 = 65.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Indiabulls LimitedIBULLSLTD | 61.8/100Mixed-positive evidence67% evidence | LEADER | 18.4/35 Revenue 100% · PAT 100% · OPM change 28 pp 71% evidence | 14.1/25 ROCE 16.2% · OPM 43% 76% evidence | 10.6/20 P/E 13× · PEG — 15% evidence | 18.7/20 RS sector 44.3% · RS bench 45% · 1Y 67.6%12 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 14.1 + 10.6 + 18.7 = 61.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3BCL Industries LtdBCLIND | 60.6/100Mixed-positive evidence87% evidence | FADING | 19.1/35 Revenue -13.1% · PAT 15.2% · OPM change 3 pp 95% evidence | 15.0/25 ROCE 13.9% · OPM 10% 95% evidence | 13.3/20 P/E 9× · PEG — 50% evidence | 13.2/20 RS sector 0.1% · RS bench 1.7% · 1Y -17.2%7 of 12 weeks ahead 100% evidence |
| Exact sum: 19.1 + 15 + 13.3 + 13.2 = 60.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Kalind Ltd526935 | 59.8/100Mixed-positive evidence82% evidence | ASLEEP | 30.6/35 Revenue 100% · PAT 100% · OPM change 21 pp 95% evidence | 18.2/25 ROCE 32% · OPM 63% 76% evidence | 10.7/20 P/E 13.9× · PEG — 50% evidence | 0.3/20 RS sector -89.6% · RS bench -36.7% · 1Y -67.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 30.6 + 18.2 + 10.7 + 0.3 = 59.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -89.6% and the one-year return is -67.4%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 5Grasim Industries LtdGRASIM | 59.1/100Mixed-positive evidence82% evidence | LEADER | 23.6/35 Revenue 19.5% · PAT 33.1% · OPM change 1 pp 95% evidence | 12.8/25 ROCE 8% · OPM 23% 76% evidence | 6.9/20 P/E 38.5× · PEG — 50% evidence | 15.8/20 RS sector 9.2% · RS bench 10.7% · 1Y 20.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 23.6 + 12.8 + 6.9 + 15.8 = 59.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 63M India Ltd3MINDIA | 54.6/100Mixed-positive evidence94% evidence | BREAKING OUT | 21.3/35 Revenue 15.7% · PAT 16.1% · OPM change -3 pp 100% evidence | 18.8/25 ROCE 50% · OPM 17% 100% evidence | 4.3/20 P/E 90.3× · PEG 3.29 100% evidence | 10.2/20 RS sector -3.7% · RS bench 4.5% · 1Y 11.8%4 of 10 weeks ahead 70% evidence |
| Exact sum: 21.3 + 18.8 + 4.3 + 10.2 = 54.6 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 7Balmer Lawrie & Company LtdBALMLAWRIE | 52.5/100Mixed-positive evidence82% evidence | ASLEEP | 16.7/35 Revenue 8.9% · PAT 3.8% · OPM change 1 pp 95% evidence | 15.2/25 ROCE 14.6% · OPM 13% 76% evidence | 14.5/20 P/E 10.6× · PEG — 50% evidence | 6.1/20 RS sector -10.1% · RS bench -8.5% · 1Y -16.5%1 of 12 weeks ahead 100% evidence |
| Exact sum: 16.7 + 15.2 + 14.5 + 6.1 = 52.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Nurture Well Industries Ltd531889 | 49.6/100Mixed-negative evidence75% evidence | ASLEEP | 19.1/35 Revenue 34% · PAT 27% · OPM change 1 pp 95% evidence | 16.6/25 ROCE 22.9% · OPM 11% 76% evidence | 11.3/20 P/E 9.1× · PEG — 15% evidence | 2.6/20 RS sector -26.7% · RS bench -25.5% · 1Y 13.5%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19.1 + 16.6 + 11.3 + 2.6 = 49.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Texmaco Infrastructure & Holdings LtdTEXINFRA | 49.3/100Mixed-negative evidence80% evidence | LEADER | 18.7/35 Revenue 5.5% · PAT 100% · OPM change -37.9 pp 95% evidence | 6.6/25 ROCE 1.4% · OPM -48.8% 95% evidence | 8.7/20 P/E 151× · PEG — 15% evidence | 15.3/20 RS sector 4.3% · RS bench 5.7% · 1Y 10.5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 18.7 + 6.6 + 8.7 + 15.3 = 49.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Bluspring Enterprises LtdBLUSPRING | 43.0/100Thin evidence · provisional57% evidence | BREAKING OUT | 18.3/35 Revenue 11.8% · PAT 90.6% · OPM change 0.7 pp 71% evidence | 3.8/25 ROCE 5.2% · OPM 2.2% 95% evidence | 8.9/20 P/E 109× · PEG — 15% evidence | 12.0/20 RS sector — · RS bench 42.5% · 1Y 37.6%10 of 10 weeks ahead 25% evidence |
| Exact sum: 18.3 + 3.8 + 8.9 + 12 = 43 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11Nava LtdNAVA | 41.4/100Mixed-negative evidence93% evidence | ASLEEP | 9.8/35 Revenue 9% · PAT -29.9% · OPM change -6 pp 100% evidence | 13.1/25 ROCE 12.8% · OPM 43% 100% evidence | 13.0/20 P/E 21.4× · PEG 1.16 65% evidence | 5.5/20 RS sector -7.8% · RS bench -6.4% · 1Y -5.6%1 of 12 weeks ahead 100% evidence |
| Exact sum: 9.8 + 13.1 + 13 + 5.5 = 41.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Tube Investments of India LtdTIINDIA | 41.3/100Mixed-negative evidence100% evidence | ASLEEP | 15.4/35 Revenue 17.6% · PAT 6.6% · OPM change -1 pp 100% evidence | 15.6/25 ROCE 17.1% · OPM 9% 100% evidence | 2.2/20 P/E 84.4× · PEG 9.63 100% evidence | 8.1/20 RS sector -6.7% · RS bench -5.3% · 1Y -4.9%7 of 12 weeks ahead 100% evidence |
| Exact sum: 15.4 + 15.6 + 2.2 + 8.1 = 41.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Andrew Yule & Company LtdANDREWYU | 35.9/100Mixed-negative evidence66% evidence | ASLEEP | 14.6/35 Revenue -4.8% · PAT -80% · OPM change 25.9 pp 95% evidence | 3.7/25 ROCE -6.3% · OPM -23.4% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 7.6/20 RS sector -37% · RS bench 6.3% · 1Y -2.1%7 of 11 weeks ahead 70% evidence |
| Exact sum: 14.6 + 3.7 + 10 + 7.6 = 35.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Swan Corp LtdSWANCORP | 32.9/100Adverse evidence69% evidence | BASING | 12.3/35 Revenue -16.7% · PAT -67.2% · OPM change -2.6 pp 95% evidence | 6.0/25 ROCE 3.9% · OPM -0.4% 76% evidence | 9.9/20 P/E 42.7× · PEG — 15% evidence | 4.7/20 RS sector -29.3% · RS bench -23.1% · 1Y -26.6%0 of 10 weeks ahead 70% evidence |
| Exact sum: 12.3 + 6 + 9.9 + 4.7 = 32.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Integrated Industries LtdIIL | 64.0/100Thin evidence · provisional50% evidence | 20.3/35 Revenue 60.5% · PAT 94.6% · OPM change 2 pp 53% evidence | 16.5/25 ROCE 30.5% · OPM 11% 57% evidence | 11.0/20 P/E 11.6× · PEG — 15% evidence | 16.2/20 RS sector 51.9% · RS bench 63.7% · 1Y 114.9%11 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 20.3 + 16.5 + 11 + 16.2 = 64 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16Arunis Abode Ltdthis pageARUNIS | 50.9/100Thin evidence · provisional45% evidence | 15.3/35 Revenue 100% · PAT 100% · OPM change -17.7 pp 40% evidence | 9.5/25 ROCE -5.3% · OPM 28.5% 57% evidence | 9.4/20 P/E 62.5× · PEG — 15% evidence | 16.7/20 RS sector 131.3% · RS bench 136.7% · 1Y 358.6%12 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 15.3 + 9.5 + 9.4 + 16.7 = 50.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Bharat Global Developers LtdBGDL | 47.0/100Thin evidence · provisional47% evidence | 15.7/35 Revenue -74% · PAT -80% · OPM change 4.2 pp 53% evidence | 10.8/25 ROCE 11.3% · OPM — 46% evidence | 8.5/20 P/E 291× · PEG — 15% evidence | 12.0/20 RS sector 165.8% · RS bench -70.1% · 1Y 22%0 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 15.7 + 10.8 + 8.5 + 12 = 47 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18Piramal Enterprises Ltd(Merged)PEL | 44.7/100Thin evidence · provisional41% evidence | 16.7/35 Revenue -35.5% · PAT 100% · OPM change -9.8 pp 27% evidence | 10.8/25 ROCE 4.9% · OPM 77.4% 57% evidence | 9.6/20 P/E 61.4× · PEG — 15% evidence | 7.6/20 RS sector -20.3% · RS bench 1% · 1Y -1.1%6 of 12 weeks ahead to 2025-09-24 70% evidence | |
| Exact sum: 16.7 + 10.8 + 9.6 + 7.6 = 44.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19Rossell India LtdROSSELLIND | 42.2/100Thin evidence · provisional47% evidence | 14.8/35 Revenue 4.8% · PAT -41.1% · OPM change 0.1 pp 36% evidence | 11.4/25 ROCE 6.4% · OPM 10.7% 71% evidence | 10.8/20 P/E 11.8× · PEG — 15% evidence | 5.2/20 RS sector -28.8% · RS bench -19.6% · 1Y -34.2%0 of 12 weeks ahead to 2026-03-29 70% evidence | |
| Exact sum: 14.8 + 11.4 + 10.8 + 5.2 = 42.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20Kesar Enterprises LtdKESAR | 33.5/100Thin evidence · provisional42% evidence | 14.2/35 Revenue -55.3% · PAT -80% · OPM change 7.4 pp 40% evidence | 5.8/25 ROCE -26.2% · OPM 2.8% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.5/20 RS sector -44.4% · RS bench -39.4% · 1Y -54.2%0 of 12 weeks ahead to 2026-03-08 70% evidence | |
| Exact sum: 14.2 + 5.8 + 10 + 3.5 = 33.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Arunis Abode Ltd's share price today?
Arunis Abode Ltd trades at ₹88.3, +1,001.2% over the past year. The company is valued at ₹1,077 Cr. The stock sits at 89% of its 52-week range of ₹7–₹98, +65.5% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 66 weeks in. — as of 14 August 2026.
What were Arunis Abode Ltd's latest quarterly results?
Arunis Abode Ltd reported revenue of ₹15.1 Cr and net profit of ₹2.5 Cr for the Dec 25 quarter. Earnings per share were ₹0.20. The operating margin was 28.5%. — as of 14 August 2026.
What is Arunis Abode Ltd's revenue?
Arunis Abode Ltd reported revenue of ₹15.1 Cr in the Dec 25 quarter. For the full FY25 fiscal year, revenue was ₹0.0 Cr (−100.0%). — as of 14 August 2026.
What is Arunis Abode Ltd's profit?
Arunis Abode Ltd earned ₹2.5 Cr of net profit in the Dec 25 quarter. Full-year FY25 profit was ₹0.0 Cr. The operating margin ran 28.5% in the latest quarter. — as of 14 August 2026.
What is Arunis Abode Ltd's market cap?
Arunis Abode Ltd's market capitalisation is ₹1,077 Cr at a share price of ₹88.3. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 14 August 2026.
What is Arunis Abode Ltd's P/E ratio?
Arunis Abode Ltd trades at a P/E of 62.5×, at the 55th percentile of its own 4-year range, against a long-run median of 59.4×. This is a comparison with the stock's own history, not a value call — as of 14 August 2026.
Does Arunis Abode Ltd pay a dividend?
No — Arunis Abode Ltd has recorded a dividend payout of 0% of profit in each of its last 4 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 14 August 2026.
Is Arunis Abode Ltd overvalued?
On its own history, Arunis Abode Ltd looks mid-range: its P/E of 62.5× sits at the 55th percentile of its 4-year range (long-run median 59.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 14 August 2026.
How is Arunis Abode Ltd performing?
Arunis Abode Ltd is in a confirmed uptrend, 66 weeks in. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 39 weeks. This describes what the data did, not a rating. — as of 14 August 2026.
Is Arunis Abode Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 66 of stage 2), trading +65.5% versus its 200-day average and at 89% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 14 August 2026.
Is Arunis Abode Ltd beating the market?
On recent form, yes — Arunis Abode Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 39 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.0 years the stock moved +58,780% against the NIFTY 500's +250% — ahead of the index over the full window. — as of 14 August 2026.
Will Arunis Abode Ltd's share price go up?
This page publishes no price forecast for Arunis Abode Ltd. What it measures instead: the share price is ₹88.3, the price is in a confirmed uptrend 66 weeks in. Its P/E of 62.5× sits at the 55th percentile of its own 4-year range. — as of 14 August 2026.
Who owns Arunis Abode Ltd?
Promoters hold 13.9% of Arunis Abode Ltd, foreign institutions null%, domestic institutions 0.7% and the public 85.4% (latest quarter). The biggest move on the register over the last two years: Promoters cut 56.3 points over 8 quarters. — as of 14 August 2026.
Does Arunis Abode Ltd have too much debt?
No — Arunis Abode Ltd's debt-to-equity is 0.17. FY25 borrowings were ₹1.0 Cr against equity of ₹6.0 Cr. The returns on this page are earned, not borrowed — as of 14 August 2026.
What is Arunis Abode Ltd's capex?
Arunis Abode Ltd spent ₹−1.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was ₹−2.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 14 August 2026.
What is Arunis Abode Ltd's cash flow?
Arunis Abode Ltd consumed ₹1.0 Cr of operating cash in FY25 — cash flowed out rather than in (free cash flow: ₹1.0 Cr). Reported profit that year was ₹0.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 14 August 2026.
Where is Arunis Abode Ltd in its business cycle?
Arunis Abode Ltd's FY24 operating margin was 49.0%, against a 3-year band of 1.0%–74.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 28.5%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 14 August 2026.
What could break the Arunis Abode Ltd story?
The sharpest disagreement: the price moved +1,001.2% in a year while annual EPS moved −133.3% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 14 August 2026.
Is Arunis Abode Ltd a stock worth studying right now?
This is not investment advice. The machine read: Arunis Abode Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 14 August 2026.